BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37116825)

  • 1. Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Edelman A; Boniface E; Schrote K; Messerle-Forbes M; O'Donnell A; Jensen JT; Han L
    Am J Obstet Gynecol; 2023 Aug; 229(2):145.e1-145.e9. PubMed ID: 37116825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Edelman AB; Kaneshiro B; Simmons KB; Hauschildt JL; Bond K; Boniface ER; Jensen JT
    Obstet Gynecol; 2020 Aug; 136(2):323-332. PubMed ID: 32649493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial.
    Simmons KB; Edelman AB; Fu R; Jensen JT
    Contraception; 2017 Feb; 95(2):198-204. PubMed ID: 27725164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a single dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users: A randomized double-blind placebo-controlled trial.
    Sinthuchai N; Tapanwong N; Apirakviriya C; Pohthipornthawat N; Santibenchakul S; Jaisamrarn U
    Contraception; 2024 Mar; 131():110354. PubMed ID: 38103854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of irregular uterine bleeding and spotting associated with Norplant.
    Archer DF; Philput CA; Weber ME
    Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
    Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
    Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Fels LM; Costescu D; Vieira CS; Peipert JF; Lukkari-Lax E; Hofmann BM; Reinecke I; Klein S; Wiesinger K; Lindenthal B; Speer R
    Am J Obstet Gynecol; 2023 Mar; 228(3):322.e1-322.e15. PubMed ID: 36424684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.
    Zigler RE; Madden T; Ashby C; Wan L; McNicholas C
    Obstet Gynecol; 2018 Oct; 132(4):888-894. PubMed ID: 30130351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
    Sørdal T; Inki P; Draeby J; O'Flynn M; Schmelter T
    Obstet Gynecol; 2013 May; 121(5):934-941. PubMed ID: 23635728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
    Cohen MA; Simmons KB; Edelman AB; Jensen JT
    Contraception; 2019 Nov; 100(5):391-396. PubMed ID: 31226322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Guiahi M; McBride M; Sheeder J; Teal S
    Obstet Gynecol; 2015 Sep; 126(3):508-513. PubMed ID: 26181091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.
    Maldonado LY; Sergison JE; Gao X; Hubacher D
    Am J Obstet Gynecol; 2020 May; 222(5):451-468.e9. PubMed ID: 31589865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.